| Completed | Post Marketing Clinical Follow up Study of HyaleXo Knee Osteoarthritis | N/A | 2024-08-02 |
| Unknown | Post Marketing Clinical Follow up Study to Evaluate the Performance and Safety of ORTHIX PLUS Osteoarthritis, Knee, Degenerative Joint Disease of Knee | — | 2022-07-01 |
| Unknown | Post Marketing Clinical Follow up Study to Evaluate the Performance and Safety of HYALEXO Osteoarthritis, Degenerative Joint Disease | — | 2022-05-01 |
| Unknown | Clinical Trial of YYC301 P3 for Treatment of Osteoarthritis of the Knee Osteoarthritis, Knee | Phase 3 | 2021-11-11 |
| Unknown | Clinical Trial to Assess the Efficacy and Safety of YYC405 in Type 2 Diabetes Patients Type 2 Diabetes | Phase 3 | 2021-07-12 |
| Unknown | Phase 3 Trial to Evaluate the Efficacy and Safety of YYC506. Dyslipidemias | Phase 3 | 2021-01-29 |
| Unknown | Phase 1 to Evaluate the Safety and Pharmacokinetic Characteristics of Fixed-dose Combination of YYC506 Dyslipidemias | Phase 1 | 2021-01-07 |
| Completed | Phase 1 to Evaluate the Safety and Pharmacokinetic Durg-drug Interaction of YYC506-T and YYC506-A Dyslipidemias | Phase 1 | 2019-11-20 |
| Completed | Clinical Trial to Assess the PK/PD of YYD601 20mg After Oral Administration if Healthy Adult Subjects (Phase1) GERD | Phase 1 | 2019-07-08 |
| Completed | Clinical Trial to Assess the Efficacy and Safety of YYD601 in NERD Patients Non-erosive Reflux Disease | Phase 3 | 2019-04-10 |
| Completed | Clinical Trial to Assess the Efficacy and Safety of YYD601 in the Treatment of Esophageal Reflux Disease (ERD) Erosive Esophagitis | Phase 3 | 2019-01-29 |
| Unknown | Evaluate the Efficacy and Safety of Short-term Administration of SIMDAX Acute Decompensated Heart Failure | Phase 3 | 2019-01-11 |
| Completed | Clinical Trial of YYC301 for Treatment of Osteoarthritis of the Knee Osteoarthritis, Knee | Phase 2 | 2018-08-30 |
| Completed | Clinical Trial of YYD302 (Phase3) for Treatment of Osteoarthritis of the Knee Osteoarthritis, Knee | Phase 3 | 2018-02-21 |
| Completed | PK/PD Clinical Trial of YYD601 in Healthy Adult Male GERD | Phase 1 | 2017-09-19 |
| Unknown | Prospective Observational Study of Pravafenix Cap Dyslipidemias | — | 2017-08-30 |
| Completed | Clinical Trial of YYD701-2 for Treatment of Nasolabial Folds Wrinkle Severity Rating Scale(WSRS) Grade 3 (Moderate) or 4 (Severe) of Nasolabial Folds | Phase 3 | 2017-03-01 |
| Completed | Clinical Trial of YYD302 for Treatment of Osteoarthritis of the Knee Osteoarthritis, Knee | Phase 1 / Phase 2 | 2016-11-01 |
| Withdrawn | Clinical Trial of YY1201 for Treatment of Osteoarthritis of the Knee Osteoarthritis, Knee | Phase 1 / Phase 2 | 2015-09-01 |
| Completed | Clinical Trial to Evaluate the Efficacy and Safety of Pravafenix Cap to Verify the Superiority Than Atorvastat Combined Dyslipidemia | Phase 3 | 2014-05-01 |
| Completed | A Observational Study to Evaluate Lipid-lowering Drug Its Effect on Parameters in Dyslipidemia of Type 2 Diabe Complex Dyslipidemia | — | 2010-10-01 |